Abstract:Adenosine deaminases acting on RNA (ADARs) catalyze adenosine (A) to inosine (I) editing of RNA that possesses double-stranded (ds) structure. A-to-I RNA editing results in nucleotide substitution, because I is recognized as G instead of A both by ribosomes and by RNA polymerases. A-to-I substitution can also cause dsRNA destabilization, as I:U mismatch base pairs are less stable than A:U base pairs. Three mammalian ADAR genes are known, of which two encode active deaminases (ADAR1 and ADAR2). Alternative promoters together with alternative splicing give rise to two protein size forms of ADAR1: an interferon-inducible ADAR1-p150 deaminase that binds dsRNA and Z-DNA, and a constitutively expressed ADAR1-p110 deaminase. ADAR2, like ADAR1-p110, is constitutively expressed and binds dsRNA. A-to-I editing occurs with both viral and cellular RNAs, and affects a broad range of biological processes. These include virus growth and persistence, apoptosis and embryogenesis, neurotransmitter receptor and ion channel function, pancreatic cell function, and post-transcriptional gene regulation by microRNAs. Biochemical processes that provide a framework for understanding the physiologic changes following ADAR-catalyzed A-to-I ( = G) editing events include mRNA translation by changing codons and hence the amino acid sequence of proteins; pre-mRNA splicing by altering splice site recognition sequences; RNA stability by changing sequences involved in nuclease recognition; genetic stability in the case of RNA virus genomes by changing sequences during viral RNA replication; and RNA-structure-dependent activities such as microRNA production or targeting or protein–RNA interactions.

Structural perspectives on adenosine to inosine RNA editing by ADARs

Adenosine Deaminase Acting on RNA 1 (ADAR1) As Crucial Regulators in Cardiovascular Diseases: Structures, Pathogenesis, and Potential Therapeutic Approach

Site-directed RNA editing by harnessing ADARs: advances and challenges

A Structural Determinant Required for Rna Editing

Site-specific regulation of RNA editing with ribose-modified nucleoside analogs in ADAR guide strands

Origins And Evolution Of Adar-Mediated Rna Editing

Adenosine Deaminases Acting on RNA, RNA Editing, and Interferon Action

Rational Design of RNA Editing Guide Strands: Cytidine Analogs at the Orphan Position

Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes

Nucleoside Analogs in ADAR Guide Strands Enable Editing at 5′-GA Sites

Origins and Evolution of ADAR‐mediated RNA Editing

Structural impacts of two disease-linked ADAR1 mutants: a molecular dynamics study

DNA editing in DNA/RNA hybrids by adenosine deaminases that act on RNA

Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs

New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins

High-throughput mutagenesis reveals unique structural features of human ADAR1

RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structure

Adenosine Deaminase Acting on RNA (ADAR) Enzymes: A Journey from Weird to Wondrous

ADAR-mediated RNA Editing in Non-Coding RNA Sequences

Mechanisms and Implications of ADAR-mediated RNA Editing in Cancer

Adenosine deaminases that act on RNA, then and now